# A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: AbbVie · Condition: Multiple Myeloma

- Company: AbbVie
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06953960

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.